Literature DB >> 8241093

Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.

R Lassila1, S Peltonen, M Lepäntalo, O Saarinen, P Kauhanen, V Manninen.   

Abstract

Immunohistochemical studies of human atherosclerotic lesions have demonstrated the occurrence of fibrin deposition and its degradation in the arterial wall. We studied fibrinogen, the generation of thrombin, and the degradation of fibrin in 40 patients with stable peripheral arterial occlusive disease of varying severity, as assessed by the ankle/brachial pressure index and duplex ultrasonography and/or angiography. Circulating fibrinogen (functional and immunological), fibrinopeptide A, thrombin-antithrombin III complex, and D-dimer were measured. The severity of atherosclerosis was associated with both fibrinogen (both functional and immunological) and D-dimer (r = .57, P < .0002, and r = .57, P < .0001, respectively). Fibrinogen and D-dimer showed a significant positive correlation (r = .50, P < .001). Generation of thrombin was detected in 24 patients (60%) by fibrinopeptide A and levels of thrombin-antithrombin III complex. As a sign of coagulation activation and fibrinolysis, we found that thrombin-antithrombin III complex and the degradation of cross-linked fibrin were progressively associated with the extent of vascular disease. The plasmin-mediated fibrin breakdown contributed to increased levels of circulating fibrinogen, an established risk factor for thrombotic complications. The significant correlations between fibrinogen/D-dimer and the severity of atherosclerosis support previous pathological studies and imply that local degradation of cross-linked fibrin is involved in the progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241093     DOI: 10.1161/01.atv.13.12.1738

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  16 in total

1.  Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study.

Authors:  Y Ueki; K Matsumoto; Y Kizaki; K Yoshida; Y Matsunaga; M Yano; S Miyake; Y Tominaga; K Eguchi
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

2.  A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

Authors:  V A Ploplis; J Wilberding; L McLennan; Z Liang; I Cornelissen; M E DeFord; E D Rosen; F J Castellino
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.

Authors:  Jade S Hiramoto; Christopher D Owens; Ji Min Kim; John Boscardin; Michael Belkin; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2012-05-25       Impact factor: 4.268

4.  Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.

Authors:  Alexander de Giorgio-Miller; Steve Bottoms; Geoffrey Laurent; Peter Carmeliet; Sarah Herrick
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

5.  Effect of Thrombin Inhibition on Patients with Peripheral Arterial Obstructive Disease: A Multicenter Clinical Trial of Argatroban.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

6.  Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.

Authors:  Takayuki Iwaki; Mayra J Sandoval-Cooper; Melissa Paiva; Takao Kobayashi; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

7.  D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy.

Authors:  Wouter J Kikkert; Bimmer E Claessen; Gregg W Stone; Roxana Mehran; Bernhard Witzenbichler; Bruce R Brodie; Jochen Wöhrle; Adam Witkowski; Giulio Guagliumi; Krzysztof Zmudka; José P S Henriques; Jan G P Tijssen; Elias A Sanidas; Vasiliki Chantziara; Ke Xu; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

8.  Blood coagulation and the risk of atherothrombosis: a complex relationship.

Authors:  Henri Mh Spronk; Danielle van der Voort; Hugo Ten Cate
Journal:  Thromb J       Date:  2004-12-01

9.  Factors associated with D-dimer levels in HIV-infected individuals.

Authors:  Alvaro H Borges; Jemma L O'Connor; Andrew N Phillips; Jason V Baker; Michael J Vjecha; Marcelo H Losso; Hartwig Klinker; Gustavo Lopardo; Ian Williams; Jens D Lundgren
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Gender-specific risk factors for peripheral artery disease in a voluntary screening population.

Authors:  Jade S Hiramoto; Ronit Katz; Steven Weisman; Michael Conte
Journal:  J Am Heart Assoc       Date:  2014-03-13       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.